167 related articles for article (PubMed ID: 33097278)
21. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
[TBL] [Abstract][Full Text] [Related]
22. Relationship between the inflammatory tumor microenvironment and different histologic types of canine mammary tumors.
de Souza TA; de Campos CB; De Biasi Bassani Gonçalves A; Nunes FC; Monteiro LN; de Oliveira Vasconcelos R; Cassali GD
Res Vet Sci; 2018 Aug; 119():209-214. PubMed ID: 29966962
[TBL] [Abstract][Full Text] [Related]
23. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
de Araújo MR; Campos LC; Ferreira E; Cassali GD
J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
[TBL] [Abstract][Full Text] [Related]
25. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
[TBL] [Abstract][Full Text] [Related]
26. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
27. Canine mammary cancer cells direct macrophages toward an intermediate activation state between M1/M2.
Beirão BC; Raposo T; Pang LY; Argyle DJ
BMC Vet Res; 2015 Jul; 11():151. PubMed ID: 26174804
[TBL] [Abstract][Full Text] [Related]
28. Influence of host factors on survival in dogs with malignant mammary gland tumors.
Philibert JC; Snyder PW; Glickman N; Glickman LT; Knapp DW; Waters DJ
J Vet Intern Med; 2003; 17(1):102-6. PubMed ID: 12564734
[TBL] [Abstract][Full Text] [Related]
29. Canine mammary cancer in overweight or obese female dogs is associated with intratumoral microvessel density and macrophage counts.
Lim HY; Seung BJ; Cho SH; Kim SH; Bae MK; Sur JH
Vet Pathol; 2022 Jan; 59(1):39-45. PubMed ID: 34547936
[TBL] [Abstract][Full Text] [Related]
30. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
[TBL] [Abstract][Full Text] [Related]
31. Relationship between major histocompatibility complex class I expression and prognosis in canine mammary gland tumors.
Tanaka T; Shimada T; Akiyoshi H; Shimizu J; Zheng C; Yijyun L; Mie K; Hayashi A; Kuwamura M; Hoshi F; Ohashi F
J Vet Med Sci; 2013 Oct; 75(10):1393-8. PubMed ID: 23728200
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer.
Gwak JM; Jang MH; Kim DI; Seo AN; Park SY
PLoS One; 2015; 10(4):e0125728. PubMed ID: 25884955
[TBL] [Abstract][Full Text] [Related]
33. Macrophages mediate a switch between canonical and non-canonical Wnt pathways in canine mammary tumors.
Król M; Mucha J; Majchrzak K; Homa A; Bulkowska M; Majewska A; Gajewska M; Pietrzak M; Perszko M; Romanowska K; Pawłowski K; Manuali E; Hellmen E; Motyl T
PLoS One; 2014; 9(1):e83995. PubMed ID: 24404146
[TBL] [Abstract][Full Text] [Related]
34. Expression of autophagy-related protein Beclin-1 in malignant canine mammary tumors.
Liu JL; Chang KC; Lo CC; Chu PY; Liu CH
BMC Vet Res; 2013 Apr; 9():75. PubMed ID: 23578251
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of angiogenesis in canine mammary tumors.
Graham JC; Myers RK
J Vet Intern Med; 1999; 13(5):416-8. PubMed ID: 10499723
[TBL] [Abstract][Full Text] [Related]
36. Density of tumor-associated macrophages (TAMs) and expression of their growth factor receptor MCSF-R and CD14 in canine mammary adenocarcinomas of various grade of malignancy and metastasis.
Król M; Pawłowski KM; Majchrzak K; Dolka I; Abramowicz A; Szyszko K; Motyl T
Pol J Vet Sci; 2011; 14(1):3-10. PubMed ID: 21528705
[TBL] [Abstract][Full Text] [Related]
37. Canine mammary gland tumors.
Sorenmo K
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):573-96. PubMed ID: 12852237
[TBL] [Abstract][Full Text] [Related]
38. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
[TBL] [Abstract][Full Text] [Related]
39. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
40. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
Nguyen F; Peña L; Ibisch C; Loussouarn D; Gama A; Rieder N; Belousov A; Campone M; Abadie J
Breast Cancer Res Treat; 2018 Feb; 167(3):635-648. PubMed ID: 29086231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
